Related Experiment Videos
Clinical role of HPV testing
1Gynecology Clinic, University of California, Santa Barbara, USA.
Obstetrics and Gynecology Clinics of North America
|December 1, 1996
Summary
Human Papillomavirus (HPV) DNA testing offers objectivity in managing cervical abnormalities, improving patient care and potentially reducing screening costs. This objective approach aids in diagnosing and treating cervical conditions, lowering cancer incidence.
Area of Science:
- Gynecologic Oncology
- Molecular Diagnostics
- Public Health Screening
Background:
- Morphologic methods in colposcopy are subjective, leading to service "swamping," increased costs, overdiagnosis, and overtreatment.
- Management of low-grade cytologic abnormalities (ASCUS and LSIL), noncorrelating Pap smears, and nondiagnostic lesions presents challenges.
Purpose of the Study:
- To highlight the role of Human Papillomavirus (HPV) DNA testing in providing objectivity for patient management.
- To explore the potential of HPV testing in improving cervical cancer screening efficiency and reducing costs.
Main Methods:
- Discusses the application of HPV DNA testing for objective assessment of various cervical cytologic and histologic findings.
- Reviews preliminary data on HPV testing as a primary screening tool for cervical cancer.
Main Results:
- HPV DNA testing provides objectivity to clarify patient management for ASCUS, LSIL, noncorrelating Pap smears, and nondiagnostic lesions.
- Preliminary data suggest HPV testing can lower cervical cancer screening costs and decrease cancer incidence.
Conclusions:
- HPV DNA testing is crucial for objective decision-making in colposcopy and managing cytologic abnormalities.
- Implementing HPV testing as a primary screen holds promise for cost-effective cervical cancer prevention.